Cambia (Diclofenac Potassium) Patent Expiration, LOE Window & CMS Spending

Cambia (Diclofenac Potassium) by Cosette: FDA Orange Book core substance LOE 2026-06-16, 6 AB generics, $1.3M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorCosette
FDA Application & PathwayN022165 (NDA)
Exclusivity / Cliff HorizonImmediate Cliff (2025-2027)
Core Active-Ingredient LOE Date2026-06-16
Last Listed Patent or Exclusivity Date2026-06-16
Orange Book Patents (*PED Extensions)4 patents (0 *PED)
Active AB-Rated Generic Competitors6
2024 CMS Total Public Spend$1.3M
2024 Medicare Part D Spend$1.3M
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel